Glenmark

Glenmark Pharma Posted Revenue Growth of 12.4 % in FY 2021-22

Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company, today announced its financial results for the fourth quarter ended March 31, 2022.

By SMEStreet Edit Desk

May 30, 2022 06:15 IST logo

4 Min read

News

Glenmark Announces Results of Phase 3 Clinical Trial of Favipiravir on COVID Patients

By SMEStreet Desk

Jul 23, 2020 05:33 IST logo

3 Min read

Glenn Saldahna, Stock Market, BSE, Glenmark Pharmaceuticals, USFDA, Acid Reflux

News

Glenmark’s Favipiravir is Different from Livealth Bio Pharma’s Livfavir

By SMEStreet Desk

Jun 25, 2020 09:45 IST logo

2 Min read

Sectors

Glenmark: Antiviral Favipiravir To Enter into Phase 3 of Clinical Trials

By SMEStreet Desk

May 26, 2020 05:53 IST logo

1 Min read

Sectors

Glenmark Begins Phase 3 of Clinical Trials on Aantiviral Favipiravir for COVID-19 Patients in India

By SMEStreet Desk

May 12, 2020 12:23 IST logo

2 Min read

Stock Market News

Glenmark, Merck to Techno Electric are Among the Newsmakers in Stock Market

By SMEStreet Desk

Aug 08, 2018 06:06 IST logo

1 Min read